Harrow (HROW) Retained Earnings (2010 - 2026)
Harrow (HROW) posted Retained Earnings of $216.6 million for Q2 2026, up 1.77% on a QoQ basis from $212.8 million in Q1 2026, and up 1.3% year-over-year from $213.8 million in Q2 2025.
Analysis
Harrow (HROW) Retained Earnings (2010 - 2026) Analysis & Trends
Harrow has reported Retained Earnings for 17 years, with the latest figure at $216.6 million in Q2 2026.
- On a quarterly basis, Retained Earnings rose 1.3% year-over-year to $216.6 million in Q2 2026; TTM through Jun 2026 was $216.6 million, a 1.3% increase from a year earlier, with the FY2025 full-year figure at $208.9 million, down 5.46% from the prior year.
- Retained Earnings was $216.6 million for Q2 2026 at Harrow, up from $212.8 million in the prior quarter.
- The five-year high for Retained Earnings was $225.6 million in Q1 2025, with the low at $107.9 million in Q1 2022.
- Average Retained Earnings over 5 years is $183.2 million, with a median of $208.5 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings soared 79.42% in 2023, then dropped 5.67% in 2026.
- Over 5 years, Retained Earnings stood at $137.1 million in 2022, then surged by 49.31% to $204.6 million in 2023, then rose by 8.0% to $221.0 million in 2024, then slipped by 5.46% to $208.9 million in 2025, then gained by 3.65% to $216.6 million in 2026.
- The last three Retained Earnings figures came in at $216.6 million (Q2 2026), $212.8 million (Q1 2026), and $208.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | -4.00 Bn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | 216.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 216.56 Mn |
| Mar 31, 2026 | 212.80 Mn |
| Dec 31, 2025 | 208.93 Mn |
| Sep 30, 2025 | 210.13 Mn |
| Jun 30, 2025 | 213.79 Mn |
| Mar 31, 2025 | 225.58 Mn |
| Dec 31, 2024 | 221.00 Mn |
| Sep 30, 2024 | 216.10 Mn |
| Jun 30, 2024 | 212.44 Mn |
| Mar 31, 2024 | 208.00 Mn |
| Dec 31, 2023 | 204.64 Mn |
| Sep 30, 2023 | 200.48 Mn |
| Jun 30, 2023 | 142.74 Mn |
| Mar 31, 2023 | 137.99 Mn |
| Dec 31, 2022 | 137.06 Mn |
| Sep 30, 2022 | 111.74 Mn |
| Jun 30, 2022 | 109.81 Mn |
| Mar 31, 2022 | 107.91 Mn |
| Dec 31, 2021 | 106.67 Mn |
| Sep 30, 2021 | 104.55 Mn |